A systematic review of the incidence and prevalence of comorbidity in multiple sclerosis: Overview

Ruth Ann Marrie, Jeffrey Cohen, Olaf Stuve, Maria Trojano, Per Soelberg Sørensen, Stephen Reingold, Gary Cutter, Nadia Reider

Research output: Contribution to journalArticle

96 Citations (Scopus)

Abstract

Background: Comorbidity is an area of increasing interest in multiple sclerosis (MS). Objective: The objective of this review is to estimate the incidence and prevalence of comorbidity in people with MS and assess the quality of included studies. Methods: We searched the PubMed, SCOPUS, EMBASE and Web of Knowledge databases, conference proceedings, and reference lists of retrieved articles. Two reviewers independently screened abstracts. One reviewer abstracted data using a standardized form and the abstraction was verified by a second reviewer. We assessed study quality using a standardized approach. We quantitatively assessed population-based studies using the I2 statistic, and conducted random-effects meta-analyses. Results: We included 249 articles. Study designs were variable with respect to source populations, case definitions, methods of ascertainment and approaches to reporting findings. Prevalence was reported more frequently than incidence; estimates for prevalence and incidence varied substantially for all conditions. Heterogeneity was high. Conclusion: This review highlights substantial gaps in the epidemiological knowledge of comorbidity in MS worldwide. Little is known about comorbidity in Central or South America, Asia or Africa. Findings in North America and Europe are inconsistent. Future studies should report age-, sex- and ethnicityspecific estimates of incidence and prevalence, and standardize findings to a common population.

Original languageEnglish (US)
Pages (from-to)263-281
Number of pages19
JournalMultiple Sclerosis
Volume21
Issue number3
DOIs
StatePublished - Mar 16 2015

Fingerprint

Multiple Sclerosis
Comorbidity
Incidence
Population
Central America
South America
North America
South Africa
PubMed
Meta-Analysis
Databases

Keywords

  • comorbidity
  • incidence
  • Multiple sclerosis
  • prevalence
  • systematic review

ASJC Scopus subject areas

  • Clinical Neurology
  • Neurology

Cite this

Marrie, R. A., Cohen, J., Stuve, O., Trojano, M., Sørensen, P. S., Reingold, S., ... Reider, N. (2015). A systematic review of the incidence and prevalence of comorbidity in multiple sclerosis: Overview. Multiple Sclerosis, 21(3), 263-281. https://doi.org/10.1177/1352458514564491

A systematic review of the incidence and prevalence of comorbidity in multiple sclerosis : Overview. / Marrie, Ruth Ann; Cohen, Jeffrey; Stuve, Olaf; Trojano, Maria; Sørensen, Per Soelberg; Reingold, Stephen; Cutter, Gary; Reider, Nadia.

In: Multiple Sclerosis, Vol. 21, No. 3, 16.03.2015, p. 263-281.

Research output: Contribution to journalArticle

Marrie, RA, Cohen, J, Stuve, O, Trojano, M, Sørensen, PS, Reingold, S, Cutter, G & Reider, N 2015, 'A systematic review of the incidence and prevalence of comorbidity in multiple sclerosis: Overview', Multiple Sclerosis, vol. 21, no. 3, pp. 263-281. https://doi.org/10.1177/1352458514564491
Marrie, Ruth Ann ; Cohen, Jeffrey ; Stuve, Olaf ; Trojano, Maria ; Sørensen, Per Soelberg ; Reingold, Stephen ; Cutter, Gary ; Reider, Nadia. / A systematic review of the incidence and prevalence of comorbidity in multiple sclerosis : Overview. In: Multiple Sclerosis. 2015 ; Vol. 21, No. 3. pp. 263-281.
@article{7ab1b3c1cf83432f9e39d551d781e050,
title = "A systematic review of the incidence and prevalence of comorbidity in multiple sclerosis: Overview",
abstract = "Background: Comorbidity is an area of increasing interest in multiple sclerosis (MS). Objective: The objective of this review is to estimate the incidence and prevalence of comorbidity in people with MS and assess the quality of included studies. Methods: We searched the PubMed, SCOPUS, EMBASE and Web of Knowledge databases, conference proceedings, and reference lists of retrieved articles. Two reviewers independently screened abstracts. One reviewer abstracted data using a standardized form and the abstraction was verified by a second reviewer. We assessed study quality using a standardized approach. We quantitatively assessed population-based studies using the I2 statistic, and conducted random-effects meta-analyses. Results: We included 249 articles. Study designs were variable with respect to source populations, case definitions, methods of ascertainment and approaches to reporting findings. Prevalence was reported more frequently than incidence; estimates for prevalence and incidence varied substantially for all conditions. Heterogeneity was high. Conclusion: This review highlights substantial gaps in the epidemiological knowledge of comorbidity in MS worldwide. Little is known about comorbidity in Central or South America, Asia or Africa. Findings in North America and Europe are inconsistent. Future studies should report age-, sex- and ethnicityspecific estimates of incidence and prevalence, and standardize findings to a common population.",
keywords = "comorbidity, incidence, Multiple sclerosis, prevalence, systematic review",
author = "Marrie, {Ruth Ann} and Jeffrey Cohen and Olaf Stuve and Maria Trojano and S{\o}rensen, {Per Soelberg} and Stephen Reingold and Gary Cutter and Nadia Reider",
year = "2015",
month = "3",
day = "16",
doi = "10.1177/1352458514564491",
language = "English (US)",
volume = "21",
pages = "263--281",
journal = "Multiple Sclerosis",
issn = "1352-4585",
publisher = "SAGE Publications Ltd",
number = "3",

}

TY - JOUR

T1 - A systematic review of the incidence and prevalence of comorbidity in multiple sclerosis

T2 - Overview

AU - Marrie, Ruth Ann

AU - Cohen, Jeffrey

AU - Stuve, Olaf

AU - Trojano, Maria

AU - Sørensen, Per Soelberg

AU - Reingold, Stephen

AU - Cutter, Gary

AU - Reider, Nadia

PY - 2015/3/16

Y1 - 2015/3/16

N2 - Background: Comorbidity is an area of increasing interest in multiple sclerosis (MS). Objective: The objective of this review is to estimate the incidence and prevalence of comorbidity in people with MS and assess the quality of included studies. Methods: We searched the PubMed, SCOPUS, EMBASE and Web of Knowledge databases, conference proceedings, and reference lists of retrieved articles. Two reviewers independently screened abstracts. One reviewer abstracted data using a standardized form and the abstraction was verified by a second reviewer. We assessed study quality using a standardized approach. We quantitatively assessed population-based studies using the I2 statistic, and conducted random-effects meta-analyses. Results: We included 249 articles. Study designs were variable with respect to source populations, case definitions, methods of ascertainment and approaches to reporting findings. Prevalence was reported more frequently than incidence; estimates for prevalence and incidence varied substantially for all conditions. Heterogeneity was high. Conclusion: This review highlights substantial gaps in the epidemiological knowledge of comorbidity in MS worldwide. Little is known about comorbidity in Central or South America, Asia or Africa. Findings in North America and Europe are inconsistent. Future studies should report age-, sex- and ethnicityspecific estimates of incidence and prevalence, and standardize findings to a common population.

AB - Background: Comorbidity is an area of increasing interest in multiple sclerosis (MS). Objective: The objective of this review is to estimate the incidence and prevalence of comorbidity in people with MS and assess the quality of included studies. Methods: We searched the PubMed, SCOPUS, EMBASE and Web of Knowledge databases, conference proceedings, and reference lists of retrieved articles. Two reviewers independently screened abstracts. One reviewer abstracted data using a standardized form and the abstraction was verified by a second reviewer. We assessed study quality using a standardized approach. We quantitatively assessed population-based studies using the I2 statistic, and conducted random-effects meta-analyses. Results: We included 249 articles. Study designs were variable with respect to source populations, case definitions, methods of ascertainment and approaches to reporting findings. Prevalence was reported more frequently than incidence; estimates for prevalence and incidence varied substantially for all conditions. Heterogeneity was high. Conclusion: This review highlights substantial gaps in the epidemiological knowledge of comorbidity in MS worldwide. Little is known about comorbidity in Central or South America, Asia or Africa. Findings in North America and Europe are inconsistent. Future studies should report age-, sex- and ethnicityspecific estimates of incidence and prevalence, and standardize findings to a common population.

KW - comorbidity

KW - incidence

KW - Multiple sclerosis

KW - prevalence

KW - systematic review

UR - http://www.scopus.com/inward/record.url?scp=84924805293&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84924805293&partnerID=8YFLogxK

U2 - 10.1177/1352458514564491

DO - 10.1177/1352458514564491

M3 - Article

C2 - 25623244

AN - SCOPUS:84924805293

VL - 21

SP - 263

EP - 281

JO - Multiple Sclerosis

JF - Multiple Sclerosis

SN - 1352-4585

IS - 3

ER -